Autonomyo prepares first product Skywalk market launch in the USA and Europe for the first half of 2026
Learn more about the market launch of Skywalk in 2026
Autonomyo is entering a decisive phase on the path toward the international launch of Skywalk, its innovative rehabilitation system designed to make walking therapy safer and more accessible both in clinics and at home.
Beginning December 1, 2025, final usability tests will start with the pre-production series at leading rehabilitation centers in Europe and the United States, including Bethesda Klinik Tschugg and UCLA California Rehabilitation Institute Los Angeles, as well as Jefferson Health / Moss Rehab in Philadelphia. These tests will prepare the system for large-scale production.
The regulatory and quality management process is progressing as planned, with FDA listing in the USA and CE marking in Europe targeted for Q1 2026.
Production of the first certified Skywalk units will begin in spring 2026, paving the way for market entry.
The official US launch will take place at the APTA Combined Sections Meeting of the American Physical Therapy Association in Anaheim, California (February 12–14, 2026). At booth #858, Autonomyo will showcase Skywalk to more than 15,000 physiotherapists, marking the company’s first major public appearance in the US rehabilitation market.
The European market introduction will follow in Q2 2026, with further clinical and commercial partnerships planned across key rehabilitation networks.